Drawing for VIVALYX

USPTO serial 79379599

VIVALYX

Reviewed by CopyMark Law Group

Reg. 7665491Status 700Registered
Filing date
Status date
Registration date
Jan 28, 2025
Examiner
FAUCETTE, MAX CLIFFORD STE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VIVALYX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristin S. Cornuelle

Kristin S. Cornuelle Orrick, Herrington & Sutcliffe LLP2050 Main Street, Suite 1100Irvine, CA 92614United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for organ transplantation, preservation, revitalization, engineering and production; pharmaceutical preparations for tissue transplantation, preservation, revitalization, engineering and production; medical preparations for use in organ and tissue transportation, preservation, revitalization, and recovery; medical preparations for use with maintaining and preserving organs outside of the living body, namely, for transportation, preservation, revitalization, and recovery; Pharmaceutical preparations for preserving donor organs and tissues; Pharmaceutical preparations for preserving organs and tissues outside of the living body; therapeutic preparations for organs, namely, preparations for organ revitalization and recovery; medical preparations for the preservation and revitalization of organs and tissues; medical preparations for maintaining and improving the quality of organs outside of the body; preservation solutions for use in maintaining and preserving donor organs and tissues; preservation solutions for use in maintaining and preserving organs and tissues outside of the living body; biological preparations for the treatment and maintenance of organs and tissues inside or outside bodies; blood substitutes for human or animal use; engineered biological soft tissues of any kind and solid organs, namely, kidney, liver, heart, lung, pancreas and intestine; pharmaceutical preparations for regenerating tissueACTIVE—
010Portable medical apparatus for transporting a harvested organ or tissue from a donor to a recipient; temperature controlled portable medical apparatus for transporting a harvested organ or tissue from a donor to a recipient; medical apparatus and instruments for preserving organs, tissues and body parts; medical apparatus for preserving organs or tissues inside or outside bodies; medical apparatus for the transportation of organs or tissues; medical apparatus and instruments for revitalizing organs, tissues and body parts; medical apparatus for revitalizing organs or tissues outside bodiesACTIVE—
039Medical transport services, namely, transportation of organs, tissues and body partsACTIVE—
042Research and development in the field of maintenance, preservation, revitalization, transportation and storage of organs in vivo and ex vivo; medical research and development in the field of perfusion of donor organs; services in relation to maintaining and improving the quality of organs in vivo or ex vivo in the nature of medical and scientific research in the field of organ and tissue preservation, revitalization and recovery; product research and development of 3d technology and processes in relation to 3d printed organ preservation and production; scientific research in the fields of three-dimensional printing; gene therapy researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 29, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 13, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 13, 2025FIMPFINAL DISPOSITION PROCESSED—
Apr 28, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 14, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 27, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 27, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 28, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 28, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 10, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 10, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 4, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 15, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 14, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 14, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 14, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 9, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 9, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 9, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 9, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 9, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 9, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 15, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Aug 15, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 15, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 15, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 13, 2024RFNTREFUSAL PROCESSED BY IB—
Apr 25, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 25, 2024RFRRREFUSAL PROCESSED BY MPU—
Apr 10, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 9, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2024DOCKASSIGNED TO EXAMINER—
Oct 3, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 29, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 28, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance